Switch to:
Varian Medical Systems Inc (NYSE:VAR)
Research and Development
$251 Mil (TTM As of Mar. 2016)

This is the expense the company spent on research and development. Varian Medical Systems Inc's research and development for the three months ended in Mar. 2016 was $62 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2016 was $251 Mil.


Definition

This is the expense the company spent on research and development.

Varian Medical Systems Inc Research & Development for the trailing twelve months (TTM) ended in Mar. 2016 was 60.01 (Jun. 2015 ) + 68.813 (Sep. 2015 ) + 59.981 (Dec. 2015 ) + 62.1 (Mar. 2016 ) = $251 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Varian Medical Systems Inc Annual Data

Sep06Sep07Sep08Sep09Sep10Sep11Sep12Sep13Sep14Sep15
Research & Development 100117136147157171186208235245

Varian Medical Systems Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Research & Development 61575957596069606265
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK